Filing Details

Accession Number:
0001438133-22-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-04 17:04:39
Reporting Period:
2022-05-02
Accepted Time:
2022-05-04 17:04:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201585 B Rebecca Robertson C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-02 1,500 $34.00 1,500 No 4 M Direct
Common Stock Disposition 2022-05-02 533 $96.05 967 No 4 S Direct
Common Stock Disposition 2022-05-02 967 $97.10 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Acquisiton 2022-05-02 1,500 $34.00 1,500 $34.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,892 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.
  3. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.60 to $96.51. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  4. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $96.77 to $97.37. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  5. The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
  6. The expiration date for these options is 10 years from the date of grant.